A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Abroad (travel likely)RecruitingPHASE3
Conditions
Chronic Inflammatory Demyelinating Polyneuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
USF Health - Morsani Center for Advanced Healthcare, Tampa, Florida, United States
Contact: Principal Investigator (Kathleen Murray)Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Contact: Principal Investigator (Victoria Lawson)Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso, Texas, United States
Contact: Principal Investigator (Aamr Herekar)
Study leads
Lakshmi Deshpande
Study Chair
Kedrion S.p.A.